02-10-2006 Comments (0)
AlphaAntihemophilic FactorCertolizumab PegolCimziaCoagulation Factor VIIaDrug DiscoveryGenentechinfliximabKeppraKeppra InjectionKeppra XRLevetiracetamLevetiracetam Extended-Release TabletsProlastinRecombinantRemicadeUCB
At its first R&D day, Belgian drugmaker UCB updated the media on its development pipeline. The firm's…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.